During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)
Studies show Dihexa significantly improves spatial learning and memory in scopolamine-induced cognitive impairment models, restoring performance to near-normal levels
With our recommended methyl B12 injections, if you do a blood test right after a 1,200 g shot, youll see around 250,000 pg/mL for a few minutes
You can typically find this information on the battery label or data sheet
GLP-1 MEDICATIONS Access, Affordability, and What Comes Next Federal Developments At the federal level, the White House announced an agreement in November with Eli Lilly and Novo Nordisk to reduce prices and expand Medicare and Medicaid coverage, including lower prices through direct-to-consumer programs